Of importance, DDR2 immunoreactivity was positively associated with the aggressive behavior of breast cancers such as a higher invasion ability (pT) and cell proliferation (Ki67), especially in the collagen type I-positive group. This evidence concerns the gene DDR2 and breast carcinoma.